Related Experiment Video
Updated: Apr 15, 2026
Analysis of Embryonic and Larval Zebrafish Skeletal Myofibers from Dissociated Preparations
Published on: November 13, 2013
In vivo characterization of human myofibrillar myopathy genes in zebrafish
John B Bührdel1, Sofia Hirth1, Mirjam Kessler1
1Department of Internal Medicine II, University of Ulm, 89081 Ulm, Germany.
Abstract:
Myofibrillar myopathies (MFM) are progressive diseases of human heart and skeletal muscle with a severe impact on life quality and expectancy of affected patients. Although recently several disease genes for myofibrillar myopathies could be identified, today most genetic causes and particularly the associated mechanisms and signaling events that lead from the mutation to the disease phenotype are still mostly unknown. To assess whether the zebrafish is a suitable model system to validate MFM candidate genes using targeted antisense-mediated knock-down strategies, we here specifically inactivated known human MFM disease genes and evaluated the resulting muscular and cardiac phenotypes functionally and structurally. Consistently, targeted ablation of MFM genes in zebrafish led to compromised skeletal muscle function mostly due to myofibrillar degeneration as well as severe heart failure. Similar to what was shown in MFM patients, MFM gene-deficient zebrafish showed pronounced gene-specific phenotypic and structural differences. In summary, our results indicate that the zebrafish is a suitable model to functionally and structurally evaluate novel MFM disease genes in vivo.
Insights
Zebrafish models effectively mimic myofibrillar myopathies (MFM), a progressive muscle disease. This study validates zebrafish as a tool for understanding MFM mechanisms and evaluating new disease genes.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular and Muscle Physiology
- Zebrafish Disease Modeling
Background:
- Myofibrillar myopathies (MFM) are debilitating progressive muscle disorders with largely unknown genetic causes and mechanisms.
- Existing knowledge gaps hinder the development of effective treatments for patients suffering from MFM.
- Identifying and validating MFM disease genes is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To determine if zebrafish are a suitable model for validating myofibrillar myopathy (MFM) candidate genes.
- To investigate the functional and structural consequences of inactivating known human MFM genes in zebrafish.
- To assess the utility of antisense-mediated knockdown strategies in zebrafish for MFM research.
Main Methods:
- Targeted antisense-mediated knockdown of known human MFM disease genes in zebrafish.
- Functional assessment of skeletal muscle performance in affected zebrafish.
- Structural analysis of myofibrillar integrity in skeletal and cardiac muscle.
- Evaluation of cardiac function and heart failure indicators.
Main Results:
- Inactivation of MFM genes in zebrafish resulted in compromised skeletal muscle function and myofibrillar degeneration.
- Zebrafish exhibited severe heart failure phenotypes consistent with MFM.
- Gene-specific phenotypic and structural differences were observed, mirroring human MFM patient presentations.
Conclusions:
- Zebrafish serve as a robust and suitable model system for the functional and structural evaluation of MFM.
- This study validates the use of zebrafish for in vivo assessment of novel MFM disease genes.
- The findings pave the way for deeper mechanistic insights into MFM pathogenesis using zebrafish models.
